What smart money is saying about Harmony Biosciences Holdings, Inc.
1 fund in our archive has pitched Harmony Biosciences Holdings, Inc. — most recently Argent Capital Management Focused Small Cap Strategy in September 2026.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
Get an email when a fund buys, sells or pitches it
Position history
Every position in Harmony Biosciences Holdings, Inc. on record in the archive was reported in Q3 2026, across 2 fund letters — 1 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 2 | 1 | 0 | 1 |
Fund activity · 2 positions · 1 move
- HoldsBridge City Capital Small Cap Growth StrategySeptember 2026
Listed in Bridge City Capital Small Cap Growth Strategy’s reported holdings.
Harmony Biosciences Holdings, Inc. - September 2026
“We also initiated a position in Harmony Biosciences, a commercial stage biotechnology company that develops and markets treatments for rare neurological disorders, led by WAKIX for excessive daytime sleepiness and cataplexy associated with narcolepsy.”
Harmony Biosciences Holdings, Inc.
Fund coverage · 1 thesis
- Argent Capital Management Focused Small Cap StrategySeptember 2026
Harmony Biosciences Holdings, Inc. markets WAKIX and other rare neurology therapies, with durable growth and pipeline optionality.
Read the full thesis
Read every full thesis on Harmony Biosciences Holdings, Inc.
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→